Very good few weeks for OSL as volume has picked up and moved it to a 12 month high as we approach a very significant moment on the 21st as OncoSil share interim data. This data will be revealed at the European Association of Nuclear Medicine which suggest OSL will be presenting positive results to do so at this event while also updating the market at the time. With OSL continuing to recruit patients at a good rate and progressing trials there is significant upside potential from its current 75 mill market cap. The pancreatic and liver cancer market potential for OncoSil's targeted radiation treatment is in the billions with next weeks interim data to really shine some light on where OSL stands in unlocking that potential. Been a long ride requiring patience but OSL look to be on the way back up as the bio space has started also to see a few movers in the sector.
OSL Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)